Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Human cytomegalovirus vaccines

Thomas C. Heineman  1
Ann Arvin  1 , Gabriella Campadelli-Fiume  2 , Edward Mocarski  3 , Patrick S. Moore  4 , Bernard Roizman  5 , Richard Whitley  6 , Koichi Yamanishi  7
, editors.
In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 71.
Affiliations
Free Books & Documents
Review

Human cytomegalovirus vaccines

Thomas C. Heineman.
Free Books & Documents

Excerpt

Efforts to develop a human cytomegalovirus (HCMV) vaccine began more than 30 years ago in response to then recent reports that HCMV was capable of causing severe congenital disease. During the intervening years, our understanding of HCMV biology and immunology has increased dramatically. That knowledge, coupled with the introduction of several new vaccine methodologies, opened the door to an impressive expansion of HCMV vaccine research, particularly during the past decade. This chapter focuses on the principles underlying HCMV vaccine development and on the vaccine approaches that are currently under investigation.

PubMed Disclaimer

References

    1. Adler S. P. Molecular epidemiology of cytomegalovirus: viral transmission among children attending a day care center, their parents, and caretakers. J. Pediatr. 1988;112:366–372. - PubMed
    1. Adler S. P. Current prospects for immunization against cytomegaloviral disease. Infect. Agents. Dis. 1996;5:29–35. - PubMed
    1. Adler S. P., Starr S. E., Plotkin S. A., et al. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 1995;171:26–32. - PubMed
    1. Adler S. P., Finney J. W., Manganello A. M., Best A. M. Prevention of child-to-mother transmision of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr. Infect. Dis. J. 1996;15:240–246. - PubMed
    1. Adler S. P., Hempfling S. H., Starr S. E., Plotkin S. A., Riddell S. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. Pediatr. Infect. Dis. J. 1998;17:200–206. - PubMed

LinkOut - more resources